NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-090-2002-1-DE-10 Assays For Assembly Of Ebola Virus Nucleocapsids DE EP 03751792.7 Expired
NIAID E-090-2002-1-FR-11 Assays For Assembly Of Ebola Virus Nucleocapsids FR EP 03751792.7 Expired
NIAID E-090-2002-1-EP-04 Assays For Assembly Of Ebola Virus Nucleocapsids EP National Stage 03751792.7 Expired
NIAID E-090-2002-1-AU-06 Assays For Assembly of Ebola Virus Nucleocapsids AU National Stage 2003269903 Expired
NIAID E-090-2002-1-IN-07 Assays For Assembly Of Ebola Virus Nucleocapsids IN National Stage 162/KOLNP/2005 Abandoned
NIAID E-090-2002-1-ZA-08 Assays For Assembly Of Ebola Virus Nucleocapsids ZA National Stage 2005/01243 Expired
NIAID E-090-2002-1-PCT-01 Assays for Assembly of Ebola Virus Nucleocapsids PCT PCT COMB PCT/US2003/021757 Expired
NIAID E-090-2002-1-JP-05 Assays For Assembly Of Ebola Virus Nucleocapsids JP National Stage 2004-521699 Abandoned
NCI E-272-2003-0-US-01 Analogs Of Thalidomide As Potential Angiogenesis Inhibitors US 60/486,515 Abandoned
NCI E-060-2000-1-US-02 SFRP and Peptide Motifs that Interact with SFRP and Methods of Their Use US National Stage 10/466,136 7488710 Expired PDF
NCI E-197-2000-0-US-03 Transfer Microdissection US National Stage 10/333,374 Abandoned
NCI E-286-2000-0-JP-05 Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms JP National Stage 2002-556736 Abandoned
NCI E-077-1999-0-US-04 Agents That Bind to and Inhibit Human Cytochrome P450 2C8, 2C9, 2C18, and 2C19 US DIV 10/616,760 7524939 Expired PDF
NIDDK E-196-2002-0-PCT-02 Alkaloid Derivatives and Methods of Their Use PCT PCT PCT/US03/021456 Expired
NCI E-285-2001-2-US-06 ANTI-TRANSFORMING GROWTH FACTOR BETA (TGF- ) TREATED STEM CELL COMPOSITION AND METHOD US DIV 10/617,108 Abandoned
CC E-254-2003-0-US-01 Method for Treatment of Cardovascular Malconditions Using Nitrides US 60/485,959 Abandoned
NIAID E-068-1998-0-US-04 INTERFERON ALPHA HYBRIDS US CON 10/615,723 7235232 Expired PDF
NICHD E-079-2003-0-US-01 Diffusion Tensor and Q-Space MRI Specimen Characterization US 60/485,658 Abandoned
NIDCR E-058-1993-0-JP-38 INHIBITION OF HIV INFECTION JP DIV 2003-271629 Abandoned
NIEHS E-139-2000-0-US-03 Use of Transgene Encoding a Vertebrate Phytase to Increase Capacity to Utilize Phytic Acid in Livestock Feed US National Stage 10/343,339 7351580 Abandoned PDF
NIMH E-068-2002-0-PCT-02 APPARATUS AND METHOD FOR IN VIRTO RECORDING AND STIMULATION OF CELLS PCT PCT PCT/US03/20971 Expired
NIDDK E-226-2003-0-US-01 Monoamine Oxidase Inhibitors US 60/484,710 Abandoned
NHLBI E-338-2007-0-US-01 Methods And Apparatus For The Selective Delipidation Of HDL US 60/484,690 Abandoned
NIMH E-068-2002-0-CA-04 APPARATUS AND METHOD FOR IN VIRTO RECORDING AND STIMULATION OF CELLS CA National Stage 2491884 Abandoned
NCI E-287-2003-0-US-01 Synthetic Antiproliferative Factor US 60/484,010 Abandoned
NCI E-063-2002-0-EP-07 SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME EP National Stage 03734363.9 Abandoned
NIAID E-096-2000-0-US-03 INDUCIBLE PLASMID VECTOR ENCODING TGF-beta AND USES THEREOF US National Stage 10/258,109 7531352 Expired PDF
NCI E-224-2003-0-US-01 Inhibition Of HIV-1 Expression By PSF US 60/484,156 Abandoned
NINDS E-143-2002-1-EP-12 Method For the Treatment of Multiple Sclerosis EP DIV 10182563.6 Abandoned
NINDS E-143-2002-1-CY-54 Method For the Treatment of Multiple Sclerosis CY EP 10182563.6 Abandoned
NINDS E-143-2002-1-BG-52 Method For the Treatment of Multiple Sclerosis BG EP 10182563.6 Abandoned
NINDS E-143-2002-1-CZ-55 Method For the Treatment of Multiple Sclerosis CZ EP 10182563.6 Abandoned
NINDS E-143-2002-1-LU-67 Method For the Treatment of Multiple Sclerosis LU EP 10182563.6 Abandoned
NINDS E-143-2002-1-NL-69 Method For the Treatment of Multiple Sclerosis NL EP 10182563.6 Abandoned
NINDS E-143-2002-1-MC-68 Method For the Treatment of Multiple Sclerosis MC EP 10182563.6 Abandoned
NINDS E-143-2002-1-PT-70 Method For the Treatment of Multiple Sclerosis PT EP 10182563.6 Abandoned
NINDS E-143-2002-1-SK-74 Method For the Treatment of Multiple Sclerosis SK EP 10182563.6 Abandoned
NINDS E-143-2002-1-SI-73 Method For the Treatment of Multiple Sclerosis SI EP 10182563.6 Abandoned
NINDS E-143-2002-1-RO-71 Method For the Treatment of Multiple Sclerosis RO EP 10182563.6 Abandoned
NINDS E-143-2002-1-AT-50 Method For the Treatment of Multiple Sclerosis AT EP 10182563.6 Abandoned
NINDS E-143-2002-1-BE-51 Method For the Treatment of Multiple Sclerosis BE EP 10182563.6 Abandoned
NINDS E-143-2002-1-HU-64 Method For the Treatment of Multiple Sclerosis HU EP 10182563.6 Abandoned
NINDS E-143-2002-1-IT-66 Method For the Treatment of Multiple Sclerosis IT EP 10182563.6 Abandoned
NINDS E-143-2002-1-GR-63 Method For the Treatment of Multiple Sclerosis GR EP 10182563.6 Abandoned
NINDS E-143-2002-1-IE-65 Method For the Treatment of Multiple Sclerosis IE EP 10182563.6 Abandoned
NINDS E-143-2002-1-TR-75 Method For the Treatment of Multiple Sclerosis TR EP 10182563.6 Abandoned
NINDS E-143-2002-1-GB-62 Method For the Treatment of Multiple Sclerosis GB EP 10182563.6 Abandoned
NINDS E-143-2002-1-ES-59 Method For the Treatment of Multiple Sclerosis ES EP 10182563.6 Abandoned
NINDS E-143-2002-1-SE-72 Method For the Treatment of Multiple Sclerosis SE EP 10182563.6 Abandoned
NINDS E-143-2002-1-CH-53 Method For the Treatment of Multiple Sclerosis CH EP 10182563.6 Abandoned